About the Company
We do not have any company description for ENZO BIOCHEM INC at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ENZO BIOCHEM INC
Enzo Biochem Shareholders Approve Merger with Bethpage
Enzo Biochem ( ($ENZB) ) has provided an update. On August 19, 2025, Enzo Biochem, Inc. held a special meeting of shareholders where they approved ...
Five new option listings and one option delisting on August 22nd
New option listings for August 22nd include Tradr 2X Long LRCX Daily ETF (LRCU), Mill City Ventures III Ltd (MCVT), Notis Global Inc (MDBX), Omada ...
Enzo Biochem Inc. - The New York Times
Enzo Biochem Inc in Farmingdale, LI, begins building sales force of its own after terminating contract with Affymetrix, its principal distributor, and filing lawsuit accusing it of improperly ...
Enzo Biochem, Inc. Notified of NYSE Non-Compliance; Plans to Address ...
Enzo Biochem, Inc. announced that it has been notified by the New York Stock Exchange (NYSE) of its non-compliance with listing standards due to its market capitalization and stockholder equity ...
Enzo Biochem, Inc. Reports Fiscal Q3 2025 Financial Results with ...
Enzo Biochem, Inc. reported financial results for its third quarter of fiscal year 2025, revealing a revenue decline of 20% to $6.4 million compared to the previous year due to challenges in the ...
Enzo Biochem, Inc. Announces Review of Strategic ... - Morningstar
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction Provided by GlobeNewswire Apr 22, 2025 5:30am ...
Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under ...
There wouldn't be many who think Enzo Biochem, Inc.'s (NYSE:ENZ) price-to-sales (or "P/S") ratio of 1.3x is worth a mention when the median P/S for the Healthcare industry in the United States is ...
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
For Enzo Biochem: For Media: For Investors: Patricia Eckert, Interim CFO 631-755-5500 Lynn Granito Berry & Company Public Relations 212-253-8881 Chris Calabrese LifeSci Advisors, LLC 917-680-5608 and ...
Enzo Biochem, Inc. (ENZ) CEO Hamid Erfanian on Q3 2022 Results ...
Enzo Biochem, Inc. (ENZ) Q3 2022 Earnings Conference Call June 10, 2022 8:30 AM ETCompany ParticipantsChris Calabrese - Investor RelationsHamid Erfanian - ...
Enzo Biochem, Inc. Enters into $8.0 Million Senior Secured Revolving ...
Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has arranged an $8 million senior secured revolving line of credit that may be increased to $12 million with Healthcare Finance Group, LLC ...
Similar Companies
Loading the latest forecasts...